{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:27:11Z","timestamp":1778084831399,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.thromres.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T02:53:34Z","timestamp":1649904814000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A FRET-based assay for the quantitation of the thrombin-factor XI interaction"],"prefix":"10.1016","volume":"214","author":[{"given":"Awital","family":"Bar Barroeta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Arnoud","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost C.M.","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2022.04.006_bb0005","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1378\/chest.124.3_suppl.4S","article-title":"Thrombin formation","volume":"124","author":"Mann","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2022.04.006_bb0010","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2005-04-1710","article-title":"Directing thrombin","volume":"106","author":"Lane","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1161\/01.ATV.0000193624.28251.83","article-title":"What does it take to make the perfect clot?","volume":"26","author":"Monroe","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2022.04.006_bb0020","series-title":"Factor XI contributes to thrombin generation in the absence of factor XII","first-page":"452","volume":"114","author":"Kravtsov","year":"2009"},{"key":"10.1016\/j.thromres.2022.04.006_bb0025","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood.V86.8.3035.3035","article-title":"Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis","volume":"86","author":"von dem Borne","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0030","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/jth.12600","article-title":"Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency","volume":"12","author":"Zucker","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.04.006_bb0035","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1182\/bloodadvances.2017015123","article-title":"Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency","volume":"2","author":"Gidley","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2022.04.006_bb0040","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1172\/JCI119412","article-title":"Thrombin-mediated activation of factor XI results in a thrombin- activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis","volume":"99","author":"Von Dem Borne","year":"1997","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2022.04.006_bb0045","first-page":"139","article-title":"Why factor XI deficiency is a clinical concern","volume":"176","author":"Wheeler","year":"2017","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.thromres.2022.04.006_bb0050","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1126\/science.1652157","article-title":"Factor XI activation in a revised model of blood coagulation","volume":"253","author":"Gailani","year":"1991","journal-title":"Science (80-.)"},{"key":"10.1016\/j.thromres.2022.04.006_bb0055","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1182\/blood-2010-10-312983","article-title":"Ingrid gailani, activation of factor XI by products of prothrombin activation","volume":"118","author":"Matafonov","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0060","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1182\/blood-2011-07-368811","article-title":"Polyphosphate is a cofactor for the activation of factor XI by thrombin","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0065","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1056\/NEJM200003093421004","article-title":"High levels of coagulation factor XI as a risk factor for venous thrombosis","volume":"342","author":"Meijers","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.thromres.2022.04.006_bb0070","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1182\/blood-2010-04-277798","article-title":"Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk","volume":"116","author":"Zhang","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0075","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1182\/blood-2016-09-742262","article-title":"Factor XI deficiency is associated with lower risk for cardiovascular and venous thromboembolism events","volume":"129","author":"Preis","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0080","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1182\/blood-2005-12-023697","article-title":"Levels of intrinsic coagulation factors and the risk of myocardial infarction among men. Opposite and synergistic effects of factor XI and XII","volume":"108","author":"Doggen","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0085","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1084\/jem.20052458","article-title":"Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis","volume":"203","author":"Kleinschnitz","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.thromres.2022.04.006_bb0090","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","article-title":"In vivo roles of factor XII","volume":"120","author":"Renn\u00e9","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0095","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2010-02-270918","article-title":"A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo","volume":"116","author":"Cheng","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/ATVBAHA.118.312328","article-title":"Contact activation inhibitor and factor XI antibody, AB023, produces safe, dose-dependent anticoagulation in a phase 1 first-in-human trial","author":"Lorentz","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2022.04.006_bb0105","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1016\/S0021-9258(20)89453-8","article-title":"Activation of human blood coagulation factor XI independent of factor XII","volume":"266","author":"Naito","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2022.04.006_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1160\/TH17-09-0676","article-title":"Chemical footprinting reveals conformational changes following activation of factor XI","volume":"118","author":"Stroo","year":"2018","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.04.006_bb0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/bs.apcsb.2017.06.001","article-title":"Using TR-FRET to investigate protein-protein interactions: a case study of PXR-coregulator interaction","volume":"110","author":"Lin","year":"2018","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.thromres.2022.04.006_bb0120","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nchembio.2007.17","article-title":"High-throughput screening assays for the identification of chemical probes","volume":"3","author":"Inglese","year":"2007","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.thromres.2022.04.006_bb0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2174\/1875397300903010022","article-title":"HTRF: a technology tailored for drug discovery \u2013a review of theoretical aspects and recent applications","volume":"3","author":"Degorce","year":"2009","journal-title":"Curr. Chem. Genomics"},{"key":"10.1016\/j.thromres.2022.04.006_bb0130","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10895-005-2826-6","article-title":"Progress in lanthanides as luminescent probes","volume":"15","author":"Hemmil\u00e4","year":"2005","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.thromres.2022.04.006_bb0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/adt.2013.507","article-title":"A time-resolved fluorescence energy transfer assay for high throughput screening of 14\u20133-3 protein-protein interaction inhibitors","volume":"11","author":"Du","year":"2013","journal-title":"Assay Drug Dev. Technol."},{"key":"10.1016\/j.thromres.2022.04.006_bb0140","unstructured":"European Lead Factory HTS assay requirements, (n.d.). https:\/\/www.europeanleadfactory.eu\/screening-requirements (accessed January 27, 2022)."},{"key":"10.1016\/j.thromres.2022.04.006_bb0145","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/jth.14612","article-title":"Polyphosphate, Zn2+ and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting","volume":"17","author":"Wang","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.04.006_bb0150","doi-asserted-by":"crossref","first-page":"45470","DOI":"10.1074\/jbc.M406727200","article-title":"Identification of a binding site for glycoprotein Ib\u03b1 in the apple 3 domain of factor XI","volume":"279","author":"Baglia","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2022.04.006_bb0155","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.1021\/bi00321a090","article-title":"Receptors for high molecular weight kininogen on stimulated washed human platelets","volume":"23","author":"Greengard","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.thromres.2022.04.006_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2017.00019","article-title":"Factors XI and XII as targets for new anticoagulants","volume":"4","author":"Weitz","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.thromres.2022.04.006_bb0165","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jth.13005","article-title":"Factor XI and contact activation as targets for antithrombotic therapy","volume":"13","author":"Gailani","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2022.04.006_bb0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/13543776.2016.1154045","article-title":"Factor XIa inhibitors: a review of patent literature Rami","volume":"26","author":"Al-Horani","year":"2016","journal-title":"Expert Opin. Therapeutic Patents"},{"key":"10.1016\/j.thromres.2022.04.006_bb0175","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1152\/physrev.00016.2011","article-title":"New fundamentals in hemostasis","volume":"93","author":"Versteeg","year":"2013","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.thromres.2022.04.006_bb0180","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood-2008-06-163675","article-title":"Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI","volume":"113","author":"Tucker","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2022.04.006_bb0185","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1538-7836.2009.03393.x","article-title":"Factor XI deficiency in animal models","volume":"7","author":"Renn\u00e9","year":"2009","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822001360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384822001360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:47:25Z","timestamp":1758736045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384822001360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":37,"alternative-id":["S0049384822001360"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2022.04.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A FRET-based assay for the quantitation of the thrombin-factor XI interaction","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}